On the issue of transmissibility of Alzheimer disease: A critical review

Prion

Volumn 6, Issue 5, 2012, Pages 447-452

  Schmidt, Christian ^a   Karch, André ^a   Korth, Carsten ^b   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer; Dementia; Epidemiology; Prion; Transmissibility

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN E; CATHEPSIN D; PRION PROTEIN; PRION PROTEIN ANTIBODY; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; MENINGITIS; MORBIDITY; MORTALITY; NEUROPATHOLOGY; NONHUMAN; POLIOMYELITIS; PRION DISEASE; PROPHYLAXIS; PROTEIN PHOSPHORYLATION; PUBLIC HEALTH; REVIEW; RISK FACTOR; SOCIAL STATUS; TRAUMATIC BRAIN INJURY; VIRUS TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; HUMANS;

ANIMALIA; RODENTIA;

EID: 84869764887     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.22502     Document Type: Review

References (66)

1. Soto C, Estrada L, Castilla J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 2006; 31:150-5; PMID:16473510; http://dx.doi.org/10.1016/j.tibs.2006.01.002.
2. Kim J, Holtzman DM. Medicine. Prion-like behavior of amyloid-beta. Science 2010; 330:918-9; PMID:21071652; http://dx.doi.org/10.1126/science. 1198314.
3. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70:532-40; PMID:22028219; http://dx.doi.org/10.1002/ana.22615.
4. Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330:980-2; PMID:20966215; http://dx.doi.org/10.1126/science.1194516.
5. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. De novo induction of amyloid-β deposition in vivo. Mol Psychiatry 2011; PMID:21968933; http://dx.doi.org/10.1038/mp.2011.120.
6. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11:909-13; PMID:19503072; http://dx.doi.org/10.1038/ncb1901.
7. Reis HJ, Mukhamedyarov MA, Rizvanov AA, Palotás A. A new story about an old guy: is Alzheimer's disease infectious? Neurodegener Dis 2010; 7:272-8; PMID:20502038; http://dx.doi.org/10.1159/000309659.
8. Sigurdsson EM, Wisniewski T, Frangione B. Infectivity of amyloid diseases. Trends Mol Med 2002; 8:411-3; PMID:12223307; http://dx.doi.org/10. 1016/S1471-4914(02)02403-6.
9. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009; 64:783-90; PMID:20064386; http://dx.doi.org/10.1016/j.neuron.2009.12.016.
10. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, et al. Induction of cerebral betaamyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A 2009; 106:12926-31; PMID:19622727; http://dx.doi.org/10.1073/pnas.0903200106.
11. Schnabel J. Amyloid: little proteins, big clues. Nature 2011; 475:S12-4; PMID:21760575; http://dx.doi.org/10.1038/475S12a.
12. Westermark GT, Westermark P. Prion-like aggregates: infectious agents in human disease. Trends Mol Med 2010; 16:501-7; PMID:20870462; http://dx.doi.org/10.1016/j.molmed.2010.08.004.
13. Mortimer JA. The Nun Study: risk factors for pathology and clinical-pathologic correlations. Curr Alzheimer Res 2012; 9:621-7; PMID:22471869.
14. SantaCruz KS, Sonnen JA, Pezhouh MK, Desrosiers MF, Nelson PT, Tyas SL. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol 2011; 70:832-40; PMID:21937909; http://dx.doi.org/10.1097/NEN.0b013e31822e8ae9.
15. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61:3688-93; PMID:2446004.
16. Goudsmit J, Morrow CH, Asher DM, Yanagihara RT, Masters CL, Gibbs CJ Jr., et al. Evidence for and against the transmissibility of Alzheimer disease. Neurology 1980; 30:945-50; PMID:6775247; http://dx.doi.org/10.1212/WNL.30.9.945.
17. Wisniewski HM, Merz GS, Carp RI. Senile dementia of the Alzheimer type: possibility of infectious etiology in genetically susceptible individuals. Acta Neurol Scand Suppl 1984; 99:91-7; PMID:6377804; http:// dx.doi.org/10.1111/j. 1600-0404.1984.tb05673.x.
18. Manuelidis EE, de Figueiredo JM, Kim JH, Fritch WW, Manuelidis L. Transmission studies from blood of Alzheimer disease patients and healthy relatives. Proc Natl Acad Sci U S A 1988; 85:4898-901; PMID:3387446; http://dx.doi.org/10.1073/pnas.85.13.4898.
19. Liberski PP. Transmissible cerebral amyloidoses as a model for Alzheimer's disease. An ultrastructural perspective. Mol Neurobiol 1994; 8:67-77; PMID:7522013; http://dx.doi.org/10.1007/BF02778009.
20. Gajdusek DC. Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses. Mol Neurobiol 1994; 8:1-13; PMID:8086124; http://dx.doi.org/10.1007/BF02778003.
21. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ. Induction of β (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 1994; 8:25-39; PMID:8086126; http://dx.doi.org/10.1007/BF02778005.
22. Brown P, Gibbs CJJ Jr., Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513-29; PMID:8179297; http://dx.doi.org/10.1002/ana.410350504.
23. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, et al. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 2000; 20:3606-11; PMID:10804202.
24. DeGiorgio LA, Manuelidis L, Bernstein JJ. Transient appearance of amyloid precursor protein plaques in the brain of thymectomized rats after human leptomeningeal cell grafts. Neurosci Lett 2002; 322:62-6; PMID:11958844; http://dx.doi.org/10.1016/S0304-3940(02)00065-4.
25. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313:1781-4; PMID:16990547; http://dx.doi.org/10. 1126/science.1131864.
26. Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M. Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci 2011; 31:14488-95; PMID:21994365; http://dx.doi.org/10.1523/ JNEUROSCI.3088-11.2011.
27. Bolton DC. Prion distribution in hamster lung and brain following intraperitoneal inoculation. J Gen Virol 1998; 79:2557-62; PMID:9780064.
28. Muramoto T, Kitamoto T, Tateishi J, Goto I. Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol 1993; 143:1470-9; PMID:8238261.
29. Prusiner SB, Cochran SP, Alpers MP. Transmission of scrapie in hamsters. J Infect Dis 1985; 152:971-8; PMID:3930630; http://dx.doi.org/10.1093/infdis/ 152.5.971.
30. Nicoll JAR, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, et al. Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol 2006; 65:1040-8; PMID:17086100; http://dx.doi.org/10.1097/01.jnen.0000240466.10758. ce.
31. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400:173-7; PMID:10408445; http://dx.doi.org/10. 1038/22124.
32. Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al.; EURODEM Risk Factors Research Group. Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20(Suppl 2):S36-42; PMID:1833352.
33. Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986; 36:922-31; PMID:3714054; http://dx.doi.org/10.1212/WNL.36.7.922.
34. Ball MJ, Lewis E, Haase AT. Detection of herpes virus genome in Alzheimer's disease by in situ hybridization: a preliminary study. J Neural Transm Suppl 1987; 24:219-25; PMID:2824690.
35. Ball MJ. Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? Le Journal Canadien Des Sciences Neurologiques 1982; 9:303-6.
36. Deatly AM, Haase AT, Fewster PH, Lewis E, Ball MJ. Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol 1990; 16:213-23; PMID:2169597; http://dx.doi.org/10.1111/j.1365-2990.1990.tb01158.x.
37. Gautrin D, Gauthier S. Alzheimer's disease: environmental factors and etiologic hypotheses. Le Journal Canadien Des Sciences Neurologiques 1989; 16:375-87.
38. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990; 28:766-74; PMID:2285263; http://dx.doi.org/10.1002/ana.410280607.
39. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15:335-41; PMID:6742780; http://dx.doi.org/10.1002/ana.410150406.
40. Middleton PJ, Petric M, Kozak M, Rewcastle NB, McLachlan DR. Herpes-simplex viral genome and senile and presenile dementias of Alzheimer and Pick. Lancet 1980; 1:1038; PMID:6103379; http://dx.doi.org/10.1016/S0140- 6736(80)91490-7.
41. Mozar HN, Bal DG, Howard JT. Perspectives on the etiology of Alzheimer's disease. JAMA 1987; 257:1503-7; PMID:2950247; http://dx.doi.org/10.1001/jama. 1987.03390110079031.
42. Taylor GR, Crow TJ, Markakis DA, Lofthouse R, Neeley S, Carter GI. Herpes simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridisation. J Neurol Neurosurg Psychiatry 1984; 47:1061-5; PMID:6094727; http://dx.doi.org/10.1136/jnnp.47.10.1061.
43. Bohnen NI, Warner MA, Kokmen E, Beard CM, Kurland LT. Prior blood transfusions and Alzheimer's disease. Neurology 1994; 44:1159-60; PMID:8208415; http://dx.doi.org/10.1212/WNL.44.6.1159.
44. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990; 40:1698-707; PMID:2146525; http://dx.doi.org/10.1212/WNL.40.11.1698.
45. O'Meara ES, Kukull WA, Schellenberg GD, Bowen JD, McCormick WC, Teri L, et al. Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype. Neuroepidemiology 1997; 16:86-93; PMID:9057170; http://dx.doi.org/10. 1159/000109675.
46. Plassman BL, Williams JWJ Jr., Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010; 153:182-93; PMID:20547887.
47. Vanderweyde T, Bednar MM, Forman SA, Wolozin B. Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. J Alzheimers Dis 2010; 22(Suppl 3):91-104; PMID:20858967.
48. Zuo C, Zuo Z. Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease. Dement Geriatr Cogn Disord 2010; 29:233-9; PMID:20375503; http://dx.doi.org/10.1159/000295114.
49. Ahlgren E, Lundqvist A, Nordlund A, Aren C, Rutberg H. Neurocognitive impairment and driving performance after coronary artery bypass surgery. Eur J Cardiothorac Surg 2003; 23:334-40; PMID:12614803; http://dx.doi.org/10.1016/ s1010-7940(02)00807-2.
50. Ancelin ML, de Roquefeuil G, Ledésert B, Bonnel F, Cheminal JC, Ritchie K. Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry 2001; 178:360-6; PMID:11282816; http://dx.doi.org/10.1192/bjp.178.4.360.
51. Bedford PD. Adverse cerebral effects of anaesthesia on old people. Lancet 1955; 269:259-63; PMID:13243706; http://dx.doi.org/10.1016/S0140-6736(55)92689- 1.
52. Fodale V, Santamaria LB, Schifilliti D, Mandal PK. Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease. Anaesthesia 2010; 65:388-95; PMID:20136805; http://dx.doi.org/10.1111/j.1365-2044.2010.06244.x.
53. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al.; International Study of Post-Operative Cognitive Dysfunction. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. Lancet 1998; 351:857-61; PMID:9525362; http://dx.doi.org/10.1016/ S0140-6736(97)07382-0.
54. O'Keeffe ST, Ní Chonchubhair A. Postoperative delirium in the elderly. Br J Anaesth 1994; 73:673-87; PMID:7826799; http://dx.doi.org/10.1093/ bja/73.5.673.
55. Seymour DG, Severn AM. Cognitive dysfunction after surgery and anaesthesia: what can we tell the grandparents? Age Ageing 2009; 38:147-50; PMID:19153069; http://dx.doi.org/10.1093/ageing/afn289.
56. Papon M-A, Whittington RA, El-Khoury NB, Planel E. Alzheimer's disease and anesthesia. Front Neurosci 2011; 4:272; PMID:21344011; http://dx.doi.org/10. 3389/fnins.2010.00272.
57. Bohnen NI, Warner MA, Kokmen E, Beard CM, Kurland LT. Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc 1994; 42:198-201; PMID:8126336.
58. Bohnen N, Warner MA, Kokmen E, Kurland LT. Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. Int J Neurosci 1994; 77:181-5; PMID:7814211; http://dx.doi.org/10.3109/00207459408986029.
59. Bufill E, Bartés A, Moral A, Casadevall T, Codinachs M, Zapater E, et al. [Genetic and environmental factors that may influence in the senile form of Alzheimer's disease: nested case control studies]. Neurologia 2009; 24:108-12; PMID:19322689.
60. Gasparini M, Vanacore N, Schiaffini C, Brusa L, Panella M, Talarico G, et al. A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci 2002; 23:11-4; PMID:12111615; http://dx.doi.org/10.1007/ s100720200017.
61. Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al.; EURODEM Risk Factors Research Group. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20(Suppl 2):S28-35; PMID:1833351.
62. Tran HT, Sanchez L, Esparza TJ, Brody DL. Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice. PLoS One 2011; 6:e25475; PMID:21980472; http://dx.doi.org/10.1371/journal.pone.0025475.
63. Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-Beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 2012; 22:142-9; PMID:21714827; http://dx.doi.org/10.1111/j.1750-3639. 2011.00513.x.
64. de Pedro Cuesta J, Ruiz Tovar M, Ward H, Calero M, Smith A, Verduras CA, et al. Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease. Neuroepidemiology 2012; 39:1-18; PMID:22777385; http://dx.doi.org/10. 1159/000339318.
65. Lollis SS, Valdes PA, Li Z, Ball PA, Roberts DW. Cause-specific mortality among neurosurgeons. J Neurosurg 2010; 113:474-8; PMID:20170305; http://dx.doi.org/10.3171/2010.1.JNS091740.
66. Thies W, Bleiler L; Alzheimer's Association. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 2011; 7:208-44; PMID:21414557; http://dx.doi.org/10.1016/j.jalz.2011.02.004.